Medical devices group Tissue Regenix signed a 10-year lease agreement on a facility to expand processing capacity at its manufacturing base in San Antonio, Texas. The agreement also included the option to purchase the facility at a later date.
The company said that it had plans to build further processing and packaging clean rooms in the new facility, increasing the company's ability to process more tissue and produce products.
'The new facility underpins the company's strategy of building strategic partnerships, accelerating US market penetration and pursuing geographic expansion opportunities,' the company said.
At 8:46am: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 3.85p